Skip to main content
SpringerLink
Log in

Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The increase in bacterial antibiotic resistance is of major concern worldwide, but pertinent epidemiologic studies have used strongly divergent approaches and are widely scattered in the literature. The aim of this study was to conduct a systematic review of studies reporting on the prevalence of antibiotic resistance in Escherichia coli in different parts of the world. Studies published from 1970 to 2006 on the prevalence of E. coli resistance were identified by a systematic Medline research and reviewed with respect to characteristics of the study design and study population, the method of resistance detection, and the prevalence of resistance. The prevalence of resistance to specific antibiotics was highly variable in different populations and in different countries and ranged from 0 to 100%. The prevalence of resistance reported in studies from Middle and South America, Spain, and Turkey was higher than that reported in the USA and Central Europe. Moreover, a tendency towards higher prevalence rates of resistance in recent years was observed. The findings indicate a need for regular monitoring of antimicrobial susceptibility rates in different human and animal populations by standardized sampling and measurement procedures. Such monitoring would help identify relevant factors that contribute to the spread of resistant pathogens and would support the prudent use of antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, Wicklund J, Miller C, Holland B, Stamey K, Barrett TJ, Rasheed LK et al (2000) Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 284:3151–3156

    Article  PubMed  CAS  Google Scholar 

  2. Kollef MH, Fraser VJ (2001) Antibiotic resistance in the intensive care unit. Ann Intern Med 134:298–314

    PubMed  CAS  Google Scholar 

  3. Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, Heine H, Monnickendam MA, Barker KF, James D, George RC (2000) Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br Med J 320:213–216

    Article  CAS  Google Scholar 

  4. Tenover FC, Hughes JM (1996) The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 275:300–304

    Article  PubMed  CAS  Google Scholar 

  5. deMan P, Verhoeven BAN, Verburgh HA, Vos MC, van den Anker JN (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978

    Article  CAS  Google Scholar 

  6. Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M (2003) Antibiotic resistance—the interplay between antibiotic use in animals and human beings. Lancet Infect Dis 3:47–51

    Article  PubMed  Google Scholar 

  7. Bartoloni A, Bartalesi F, Mantella A, Dell’Amico E, Roselli M, Strohmeyer M, Barahona HG, Barron VP, Paradisi F, Rossolini GM (2004) High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J Infect Dis 189:1291–1294

    Article  PubMed  CAS  Google Scholar 

  8. Lester SC, del Pilar Pla M, Wang F, Perez Schael I, Jiang H, O’Brien TF (1990) The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 323:285–289

    Article  PubMed  CAS  Google Scholar 

  9. Kahlmeter G, ECO.SENS (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51:69–76

    Article  PubMed  CAS  Google Scholar 

  10. Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 50:59–69

    Article  PubMed  CAS  Google Scholar 

  11. von Baum H, Marre R (2005) Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol 295:503–511

    Article  CAS  Google Scholar 

  12. Bonten M, Stobberingh E, Philips J, Houben A (1992) Antibiotic resistance of Escherichia coli in fecal samples of healthy people in two different areas in an industrialized country. Infection 20:258–262

    Article  PubMed  CAS  Google Scholar 

  13. Calva JJ, Sifuentes-Osornio J, Ceron C (1996) Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico. Antimicrob Agents Chemother 40:1699–1702

    PubMed  CAS  Google Scholar 

  14. Dominguez E, Zarazaga M, Saenz Y, Brinas L, Torres C (2002) Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain. Microb Drug Resist 8:321–327

    Article  PubMed  CAS  Google Scholar 

  15. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, Llovet T, Ruiz-Bremon A (1999) Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 43:2736–2741

    PubMed  CAS  Google Scholar 

  16. Gulay Z, Bicmen M, Amyes SG, Yulug N (2002) Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers. J Chemother 12:208–215

    Google Scholar 

  17. London N, Nijsten R, van der Bogaard A, Stobberingh E (1994) Carriage of antibiotic-resistant Escherichia coli by healthy volunteers during a 15-week period. Infection 22:187–192

    Article  PubMed  CAS  Google Scholar 

  18. Stürmer T, Erb A, Marre R, Brenner H (2004) Prevalence and determinants of colonisation with antibiotic-resistant Escherichia coli in unselected patients attending general practitioners in Germany. Pharmacoepidemiol Drug Saf 13:303–308

    Article  PubMed  Google Scholar 

  19. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (2000) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359–365

    Article  Google Scholar 

  20. Brumfitt W, Faiers MC, Reeves DS, Datta N (1971) Antibiotic-resistant Escherichia coli causing urinary-tract infection in general practice: relation to faecal flora. Lancet 1:315–317

    Article  Google Scholar 

  21. Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, Pfaller MA, Doern GV (2000) Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother 45:295–303

    Article  PubMed  CAS  Google Scholar 

  22. Gupta K, Sahm DF, Mayfield D, Stamm WE (2001) Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 33:89–94

    Article  PubMed  CAS  Google Scholar 

  23. Huovinen P, Toivanen P (1980) Trimethoprim resistance in Finland after five years’ use of plain trimethoprim. Br Med J 280:72–74

    Article  PubMed  CAS  Google Scholar 

  24. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF (2002) Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 46:2540–2545

    Article  PubMed  CAS  Google Scholar 

  25. Vorland LH, Carlson K, Aalen O (1985) Antibiotic resistance and small R plasmids among Escherichia coli isolates from outpatient urinary tract infections in northern Norway. Antimicrob Agents Chemother 27:107–113

    PubMed  CAS  Google Scholar 

  26. Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ (2000) A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 44:1089–1092

    Article  PubMed  CAS  Google Scholar 

  27. Zhanel GG, Hisanaga TL, Laing NM, Decorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA, for the NAUTICA Group, Hoban DJ (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27:468–475

    Article  PubMed  CAS  Google Scholar 

  28. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J (2000) Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 30:454–460

    Article  PubMed  CAS  Google Scholar 

  29. Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J, Spanish members of EARSS (2005) Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 11:546–553

    PubMed  CAS  Google Scholar 

  30. Reynolds R, Potz N, Colman M, Williams A, Livermore D, MacGowan A, and the BSAC extended working party on bacteraemia resistance surveillance (2004) Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001–2002: the BSAC Bacteraemia Resistance Surveillance Programme. J Antimicrob Chemother 53:1018–1032

    Article  PubMed  CAS  Google Scholar 

  31. Shannon KP, French GL (2002) Antibiotic resistance: effect of different criteria for classifying isolates as duplicates on apparent resistance frequencies. J Antimicrob Chemother 49:201–204

    Article  PubMed  CAS  Google Scholar 

  32. Kresken M, Hafner D (1999) Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975–1995. Study group bacterial resistance of the Paul–Ehrlich-society for chemotherapy. Infection 27 (Suppl 2):2–8

    Google Scholar 

  33. Gould IM (2000) Towards a common susceptibility testing method. J Antimicrob Chemother 45:757–762

    Article  PubMed  CAS  Google Scholar 

  34. Chulain MN, Murray AM, Corbett-Feeney G, Cormican M (2005) Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 174:6–9

    Article  PubMed  CAS  Google Scholar 

  35. Bartolini A, Pallecchi L, Benedetti M, Fernandez C, Vallejos Y, Guzman E, Villagran AL, Mantella A, Lucchetti C, Bartalesi F, Strohmeyer M, Bechini A, et al (2006) Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 12:907–913

    Google Scholar 

  36. Ishii Y, Alba J, Kimura S, Yamaguchi K (2006) Evaluation of antimicrobial activity of beta-lactam antibiotics by E test against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis 55:143–148

    Article  PubMed  CAS  Google Scholar 

  37. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657–686

    Article  PubMed  CAS  Google Scholar 

  38. Pitout JD, Hanson ND, Church DL, Laupland KB (2004) Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis 38:1736–1741

    Article  PubMed  CAS  Google Scholar 

  39. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089–1094

    Article  PubMed  Google Scholar 

  40. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163–167

    Article  PubMed  CAS  Google Scholar 

  41. Davison HC, Low JC, Woolhouse MEJ (2000) What is antibiotic resistance and how can we measure it? Trends Microbiol 8:554–559

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology, German Centre for Research on Aging, Bergheimer Straβe 20, 69115, Heidelberg, Germany

    A. Erb, T. Stürmer & H. Brenner

  2. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Straβe 20, 69115, Heidelberg, Germany

    H. Brenner

  3. Department of Microbiology and Hygiene, University of Ulm, Robert-Koch-Straβe 8, 89081, Ulm, Germany

    R. Marre

Authors
  1. A. Erb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Stürmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Marre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Brenner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erb, A., Stürmer, T., Marre, R. et al. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 26, 83–90 (2007). https://doi.org/10.1007/s10096-006-0248-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-006-0248-2

Keywords

Search

Navigation